C-reactive protein levels and outcomes in infarct-related cardiogenic shock: data from the ECLS-SHOCK trial
- 30 December 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 14 (2) , 59-70
Abstract
Aims: The impact of systemic inflammation in acute myocardial infarction complicated by cardiogenic shock (AMI-CS) is still a matter of debate. The present ECLS-SHOCK sub-study investigates the association of C-reactive protein (CRP) levels with short-term outcomes in patients with AMI-CS. Methods and results: Patients with AMI-CS enrolled in the multicentre, randomized ECLS-SHOCK trial between 2019 and 2022 were included. The prognostic impact of CRP levels on admission, as well as the effect of extracorporeal life support (ECLS), stratified by CRP levels, was tested with regard to the primary endpoint of 30-day all-cause mortality. In 371 patients with AMI-CS and available CRP level on baseline, the median CRP level was 18.0 mg/L. Patients with CRP levels in the highest tertile were older and less often resuscitated from cardiac arrest. The highest tertile (i.e. CRP >61.0 mg/L) was associated with an increased risk of 30-day all-cause mortality compared with patients with lower CRP levels (lowest tertile: ≤5.0 mg/L) [adjusted odds ratio: 3.54; 95% confidence interval (CI) 1.88–6.68; P = 0.001]. The use of ECLS did not reduce 30-day all-cause mortality, irrespective of CRP levels on admission. The additional inclusion of CRP to the IABP-SHOCK II score was associated with a slight improvement of the prediction of 30-days all-cause mortality (area under the curve: 0.74; 95% CI 0.68–0.79). Conclusion: Higher CRP levels were independently associated with the risk of 30-day all-cause mortality in AMI-CS. The additional inclusion of CRP to a validated CS risk score may further improve the prediction of short-term prognosis.Keywords
Funding Information
- Else Kröner Fresenius Foundation
- German Heart Research Foundation
- Helios Health Institute
- Leipzig Heart Institute
This publication has 32 references indexed in Scilit:
- Association of systemic inflammation with shock severity, 30-day mortality, and therapy response in patients with cardiogenic shockClinical Research in Cardiology, 2023
- Prognosis of cardiogenic shock with and without acute myocardial infarction: results from a prospective, monocentric registryClinical Research in Cardiology, 2023
- Biomarkers in cardiogenic shock2022
- Cardiogenic Shock After Acute Myocardial InfarctionJAMA, 2021
- Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock - Design and rationale of the ECLS-SHOCK trialAmerican Heart Journal, 2021
- Multimarker Approach Including CRP, sST2 and GDF-15 for Prognostic Stratification in Stable Heart FailureESC Heart Failure, 2020
- Possible mechanisms of C-reactive protein mediated acute myocardial infarctionEuropean Journal of Pharmacology, 2015
- Clinical Picture and Risk Prediction of Short-Term Mortality in Cardiogenic ShockEuropean Journal of Heart Failure, 2015
- Pathophysiology, diagnosis, and treatment of infarction-related cardiogenic shockHerz, 2011
- C-reactive protein in atherosclerosis: A causal factor?Cardiovascular Research, 2006